These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 24737903)

  • 41. Antineutrophil cytoplasmic antibodies (ANCA): diagnostic utility and potential role in the pathogenesis of vasculitis.
    Malenica B; Rudolf M; Kozmar A
    Acta Dermatovenerol Croat; 2004; 12(4):294-313. PubMed ID: 15588565
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of MPO-ANCA and PR3-ANCA immunoassays for the stratification of specific ANCA-associated vasculitis: A systematic review and meta-analysis.
    Walker BS; Peterson LK; Koening C; White SK; Schmidt RL; Tebo AE
    Autoimmun Rev; 2022 Jun; 21(6):103100. PubMed ID: 35452854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative investigation of respiratory tract involvement in granulomatosis with polyangiitis between PR3-ANCA positive and MPO-ANCA positive cases: a retrospective cohort study.
    Ikeda S; Arita M; Misaki K; Kashiwagi Y; Ito Y; Yamada H; Hotta M; Nishiyama A; Ito A; Noyama M; Koyama T; Notohara K; Ishida T
    BMC Pulm Med; 2015 Jul; 15():78. PubMed ID: 26223225
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myeloperoxidase anti-neutrophil cytoplasmic antibody affinity is associated with the formation of neutrophil extracellular traps in the kidney and vasculitis activity in myeloperoxidase anti-neutrophil cytoplasmic antibody-associated microscopic polyangiitis.
    Yoshida M; Yamada M; Sudo Y; Kojima T; Tomiyasu T; Yoshikawa N; Oda T; Yamada M
    Nephrology (Carlton); 2016 Jul; 21(7):624-9. PubMed ID: 26833773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathways to ANCA production: from differentiation of dendritic cells by proteinase 3 to B lymphocyte maturation in Wegener's granuloma.
    Csernok E; Moosig F; Gross WL
    Clin Rev Allergy Immunol; 2008 Jun; 34(3):300-6. PubMed ID: 18181035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
    Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
    J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis.
    Bossuyt X; Cohen Tervaert JW; Arimura Y; Blockmans D; Flores-Suárez LF; Guillevin L; Hellmich B; Jayne D; Jennette JC; Kallenberg CGM; Moiseev S; Novikov P; Radice A; Savige JA; Sinico RA; Specks U; van Paassen P; Zhao MH; Rasmussen N; Damoiseaux J; Csernok E
    Nat Rev Rheumatol; 2017 Nov; 13(11):683-692. PubMed ID: 28905856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antineutrophil cytoplasmic autoantibodies, autoantigens, and systemic vasculitis.
    Gross WL; Csernok E; Helmchen U
    APMIS; 1995 Feb; 103(2):81-97. PubMed ID: 7748541
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
    Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
    Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
    Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
    Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.
    Hauer HA; Bajema IM; van Houwelingen HC; Ferrario F; Noël LH; Waldherr R; Jayne DR; Rasmussen N; Bruijn JA; Hagen EC;
    Kidney Int; 2002 Jan; 61(1):80-9. PubMed ID: 11786087
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies.
    Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H;
    Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management.
    Trivioli G; Marquez A; Martorana D; Tesi M; Kronbichler A; Lyons PA; Vaglio A
    Nat Rev Rheumatol; 2022 Oct; 18(10):559-574. PubMed ID: 36109667
    [TBL] [Abstract][Full Text] [Related]  

  • 55. -463 G/A myeloperoxidase promoter polymorphism is associated with clinical manifestations and the course of disease in MPO-ANCA-associated vasculitis.
    Reynolds WF; Stegeman CA; Tervaert JW
    Clin Immunol; 2002 May; 103(2):154-60. PubMed ID: 12027420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The environment, geoepidemiology and ANCA-associated vasculitides.
    Chen M; Kallenberg CG
    Autoimmun Rev; 2010 Mar; 9(5):A293-8. PubMed ID: 19892038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis.
    Harper L; Cockwell P; Adu D; Savage CO
    Kidney Int; 2001 May; 59(5):1729-38. PubMed ID: 11318943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies.
    Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL
    J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Effect of Alpha-1 Antitrypsin Deficiency in Antineutrophil Cytoplasmic Antibody-associated Vasculitis: Results from a French Retrospective Monocentric Cohort.
    Deshayes S; Martin Silva N; Grandhomme F; Khoy K; Mariotte D; Boutemy J; Maigné G; Brière-Bellier C; Delmas C; Bienvenu B; Lobbedez T; de Boysson H; Aouba A
    J Rheumatol; 2019 Nov; 46(11):1502-1508. PubMed ID: 30824651
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
    Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
    Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.